Immediate Impact

1 from Science/Nature 49 standout
Sub-graph 1 of 24

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
3 intermediate papers

Works of Jiří Voller being referenced

Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity
2011

Author Peers

Author Last Decade Papers Cites
Jiří Voller 335 139 115 184 29 640
Jayoung Song 405 64 121 263 32 700
Raj Kumar Mongre 325 84 80 107 34 701
Laura Toccacieli 280 105 126 68 17 640
Mann-Jen Hour 354 47 75 273 17 661
Craig Hill 191 116 128 99 31 731
Ori Kalid 507 38 75 99 16 678
Ahmed M. Ali 313 55 119 225 31 722
Nelson José Freitas da Silveira 429 40 139 56 43 691
Sheng Tang 365 51 66 225 43 718
Sijin Wu 456 44 107 90 50 714

All Works

Loading papers...

Rankless by CCL
2026